Soluble VE-cadherin (sVE-cadherin) was listed among the endothelial dysfunction markers related to endothelial inflammation, thrombosis, glycocalyx damage, vascular tone in COVID-19 patients (Xu et al., 2023). This evidence concerns the gene CDH5 and endothelial dysfunction.